HAEMOSTASIS ASSAYS: PROBLEMS IN STANDARDIZATION
FIBRINOGEN ASSAYS
PROBLEMS WITH TESTS AND ASSAYS OF THE PROTEIN C/PROTEIN S SYSTEM
HEPARIN MONITORING
NEW CONDITIONING REGIMENS FOR TRANSPLANTATION
HLA MATCHING IN BONE MARROW TRANSPLANTATION
XENOTRANSPLANTATION IN THE NEXT MILLENNIUM
DIAGNOSTIC STRATEGIES FOR THE INVESTIGATION OF SUSPECTED VENOUS THROMBOEMBOLISM
THE DURATION OF ANTICOAGULANT TREATMENT FOR PATIENTS WITH VENOUS THROMBOEMBOLISM
LMWH HEPARINS IN THE TREATMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM
FRAGILE SITES, REPEAT SEQUENCES AND THE RISK OF HAEMATOLOGICAL MALIGNANCY
DEFECTS OF DNA MISMATCH REPAIR IN ACUTE MYELOBLASTIC LEUKAEMIA
XENOBIOTIC METABOLISM AND RISK OF MALIGNANCY
DNA REPAIR PATHWAYS AND THE RISK OF MALIGNANCY
ATAXIA-TELANGIECTASIA AND THE RISK OF LEUKAEMIA AND LYMPHOMA
LIFE WITHOUT DNA REPAIR - IMPLICATIONS FOR TOXICITY AND MUTAGENESIS IN THE BONE MARROW
BLEEDING PROBLEMS IN WOMEN
THE INVESTIGATION AND MANAGEMENT OF WOMEN WITH MENORRHAGIA
BLEEDING DISORDERS AND PREGNANCY
THE SCIENTIFIC BASIS AND UTILITY OF THE NEW WHO CLASSIFICATION
THE DIAGNOSIS OF B-CELL LYMPHOMA USING FISH ANALYSIS
THE GENETICS AND CLASSIFICATION OF CLL
ORAL CONTRACEPTIVES AND THROMBOSIS
THROMBOSIS RISK FACTORS AND VASCULAR DISORDERS IN PREGNANCY
THE BALANCE OF THROMBOTIC BENEFITS AND RISKS FOR HORMONE REPLACEMENT THERAPY
GENE TRANSFER INTO PRIMARY AML BLASTS AND MYELOID LEUKAEMIA CELL LINES.
DIFFERENTIATION OF PRIMARY AML BLASTS AND MYELOID LEUKAEMIA CELL LINES INTO DENDRITIC LIKE CELLS BY CULTURE WITH CD40 LIGAND.
STIMULATION OF AUTOLOGOUS PROLIFERATIVE AND CYTOTOXIC T CELL RESPONSES BY "LEUKAEMIC DENDRITIC CELLS" GENERATED FROM AML BLASTS.
THE IMPLICATION OF COMPROMISED RENAL FUNCTION AT PRESENTATION IN MYELOMA - SIMILAR OUTCOME IN PATIENTS WHO RECEIVE HIGH-DOSE THERAPY(HDT) : A SINGLE CENTRE STUDY OF 251 PREVIOUSLY UNTREATED PATIENTS
Thromboelastography: A reliable test?
INDUCTION OF T CELL RESPONSES AGAINST MULTIPLE MYELOMA-ASSOCIATED ANTIGENS BY DENDRITIC CELLS
ROUTINE HAEMATOLOGICAL AND HAEMODYNAMIC PARAMETERS DO NOT PREDICT MEASURED BLOOD VOLUME IN THE CRITICALLY ILL.
WT1 GENE AS A MARKER FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE LEUKAEMIA.
QUANTITATION OF CYCLIN D1 OVEREXPRESSION - A TOOL FOR DIAGNOSIS AND MONITORING OF MANTLE CELL LYMPHOMA
ALTERED SURFACE PHENOTYPE AND INTERLEUKIN-10 PRODUCTION BY MONOCYTES IN G-CSF-MOBILIZED PERIPHERAL BLOOD STEM CELL TRANSPLANTS CORRELATE WITH GRAFT-VERSUS HOST DISEASE (GVHD).
HOME CHEMOTHERAPY FOR HAEMATOLOGICAL MALIGNANCIES - AN INITIAL EXPERIENCE.
COMBINATION OF AZOLES AND AMPHOTERICIN B SUSPENSION FOR THE PREVENTION OF CANDIDA COLONISATION AND INFECTIONS.
LOVASTATIN AND ATRA IN COMBINATION ENHANCE THE GROWTH OF MYELOID CELLS IN VITRO.
32D CELLS EXPRESSING EITHER AML1-ETO, AML1A OR AML1-MDS GENES SHOW DIFFERING SENSITIVITY TO TRICHOSTATIN (TSA), A HISTONE DEACETYLASE INHIBITOR.
THE EFFECT OF AN AMLI/ETO FUSION GENE ON GENE EXPRESSION IN THE 32DC13 CELL LINE.
INHIBITION OF THE ONCOGENE FUS (TLS) MAY PROMOTE NEUTROPHIL DIFFERENTIATION.
DUAL COLOUR FISH IN BONE MARROW TREPHINE BIOPSIES FOR THE IDENTIFICATION OF THE PHILADELPHIA CHROMOSOME IN ACUTE LYMPHOBLASTIC LEUKAEMIA.
INVESTIGATION OF hMSH2 AND hMLH1 PROMOTER HYPERMETHYLATION IN AML AND MDS PATIENTS.
MICROSATELLITE INSTABILITY IN ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROME.
CLEAVAGE OF PML-RARA FUSION TRANSCRIPT BY HAMMERHEAD RIBOZYMES AND DNAZYMES.
A RANDOMISED STUDY COMPARING AN ORAL REGIMEN (IDARUBICIN AND ETOPOSIDE) WITH AN (NTRAVENOUS REGIMEN (MAE) FOR CONSOLIDATION IN PATIENTS OVER 55 YEARS WITH ACUTE MYELOID LEUKAEMIA IN FIRST COMPLETE REMISSION
CLONALITY ANALYSIS OF REED-STERNBERG CELLS IN HODGKIN'S DISEASE
VALUE OF FLOW CYTOMETRY (FC) ON LYMPH NODES (LNs) AND EXTRANODAL TISSUE SAMPLES IN THE DIAGNOSIS OF PATIENTS WITH SUSPECTED NON-HODGKIN'S LYMPHOMA.
AN INVESTIGATION INTO THE IN VITRO EFFECTS OF A BCL-2 ANTISENSE OLIGONUCLEOTIDE AND CHLORAMBUCIL ON B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS
BRYOSTATIN - DIFFERENTIATION AND APOPTOSIS IN B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA
IDENTIFICATION OF NOVEL REGIONS OF AMPLIFICATION AND DELETION WITHIN MANTLE CELL LYMPHOMA DNA BY COMPARATIVE GENOMIC HYBRIDIZATION
MULTIDRUG TRANSPORTER PROTEIN EXPRESSION AND FUNCTION: CLINICAL IMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKAEMIA.
GEMCITABINE IN THE TREATMENT OF RELAPSED AND REFRACTORY LYMPHOID MALIGNANCIES
DISCORDANT SOMATIC MUTATION OF IMMUNOGLOBULIN VARIABLE REGION GENES AND BCL-6 GENES IN CHRONIC LYMPHOCYTIC LEUKEMIA
ADULT T-CELL LEUKAEMIA/LYMPHOMA IN ENGLAND 1996-1999: HIGH MORTALITY, YOUNGER PATIENTS AND MORE COMMON THAN EXPECTED
DEFECTIVE EXPRESSION OF ATM AS A CAUSE OF p53 DYSFUNCTION IN B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA.
EXTRACELLULAR CATALASE AS AN AUTOCRINE SURVIVAL FACTOR IN CHRONIC LYMPHOCYTIC LEUKAEMIA.
ABNORMAL LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND SOLUBLE RECEPTOR (sFLT-1) IN PATIENTS WITH ATHEROSCLEROSIS
VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND SOLUBLE VEGF RECEPTOR (sFLT-1) IN HAEMATOLOGICAL CANCER
PREDICTION OF PRIMITIVE HAEMOPOIETIC PROGENITOR CELL FREQUENCY IN APLASTIC ANAEMIA
CLINICAL EXPERIENCE WITH THE USE OF rhG-CSF IN AUTOIMMUNE NEUTROPENIA
CD77 EXPRESSION IS DIFFERENT IN MULTIPLE MYELOMA AND PLASMACYTOMA.
MYELOMA AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
CIRCUMVENTING MYELOMA TUMOUR-ASSOCIATED IMMUNOSUPPRESSION - THE ROLE OF IL-15 AND OTHER INFLAMMATORY STIMULI.
THE USE OF FLUORO-DEOXYGLUCOSE (FDG) PET IMAGING FOR THE DETECTION OF OCCULT DISEASE IN MULTIPLE MYELOMA.
BENCE-JONES (BJ) MYELOMA: A DISTINCT ENTITY COMPARED TO IgG AND IgA MYELOMA
THE VARIATION OVER TIME OF THE BCR-ABL STATUS OF NON-CML PATIENTS AND NORMAL INDIVIDUALS
FUNCTIONAL SUPPRESSION OF CYCLIN DEPENDENT KINASE-1 IS INDICATIVE OF SUSCEPTIBILITY TO DRUG INDUCED APOPTOSIS.
CLINICAL CHARACTERISTICS HYDROXYUREA INDUCED CUTANEOUS ULCERS IN 8 PATIENTS
THE SEQUENTIAL EXPOSURE OF 5-AZA-2′DEOXYCYTIDINE AND GM-CSF SLOWS MYELOID CELL PROLIFERATION AND INDUCES DIFFERENTIATION.
SERUM ERYTHROPOIETIN IN THE ERYTHROCYTOSES; IS A LOW VALUE SPECIFIC FOR POLYCYTHAEMIA VERA?
IDIOPATHIC ERYTHROCYTOSIS: THE CLINICAL AND LABORATORY SPECTRUM
SAGITTAL SINUS THROMBOSIS IN MYELOPROLIFERATIVE DISORDERS.
A STUDY OF 22 CASES OF TRANSFUSION RELATED ACUTE LUNG INJURY (TRALI).
P21 EXPRESSION IN CULTURED MEGAKARYOCYTES FROM NORMAL DONORS IS INVERSELY PROPORTIONAL TO GPIb EXPRESSION
4-1BBL ENHANCES ANTI-TUMOR RESPONSES IN THE PRESENCE OR ABSENCE OF CD28 BUT B7-2 SIGNALING IS REQUIRED FOR LONG TERM SYSTEMIC IMMUNITY.
EFFECT OF LEUKEMIC CELLS ON THE DIFFERENTIATION OF NORMAL MONOCYTE-DERIVED DENDRITIC CELLS: A PHENOTYPIC AND FUNCTIONAL ANALYSIS.
THE RETINOBLASTOMA FAMILY MEMBER, p107, IS ACTIVE IN NON-DIVIDING MONOCYTE-DERIVED DENDRITIC CELLS.
RE-EMERGENCE OF QUIESCENT SARCOIDOSIS AFTER FLUDARABINE TREATMENT FOR LOW GRADE B -NHL
Acquired pure red cell aplasia due to treatment induced erythropoietin antibodies
DIETARY VITAMIN B12 DEFICIENCY IN AN ADOLESCENT CAUCASIAN
ANTENATAL TESTING FOR HAEMOGLOBINOPATHIES
ANTENATAL HAEMOGLOBINOPATHY SCREENING
TWO CASES OF POST TRANSFUSION HYPERHAEMOLYSIS IN SICKLE CELL DISEASE.
VARIATION OF HB F AND F CELL LEVELS IN RELATION TO CIS REGULATORY SEQUENCES IN THE β GLOBIN GENE CLUSTER
REDUCING HOSPITAL DEPENDENCY IN SICKLE CELL DISEASE; CAN PAINFUL CRISES BE MANAGED AT HOME?
THE USE OF HYDROXYUREA (HU) IN THALASSAEMIC AND SICKLE SYNDROMES: EARLY RESULTS FROM A LONDON DISTRICT HOSPITAL.
RESPONSE TO BISPHOSPHONATE THERAPY FOR OSTEOPOROSIS IN THALASSAEMIA MAJOR.
SELECTIVE ANTENATAL HAEMOGLOBINOPATHY SCREENING IN A LONDON BOROUGH WITH A HIGH ETHNIC MINORITY POPULATION.
WHEN IS A MINOR HAEMOGLOBIN FRACTION WORTHY OF INVESTIGATION?
AN AUDIT OF BLOOD WARMERS
ANTI-U HAEMOLYTIC DISEASE OF THE NEWBORN IN SUCCESSIVE PREGNANCIES
THE USE OF THROMBOELASTOGRAPHY TO ENSURE APPROPRIATE USE OF BLOOD PRODUCTS IN CARDIAC SURGERY.
PHASE 1 EVALUATION OF THE AMICUS™ BLOOD CELL SEPARATOR BY THE WELSH BLOOD SERVICE.
NO ASSOCIATION BETWEEN NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, ALONE OR WITH PROPHYLACTIC ANTICOAGULANTS, AND BLOOD TRANSFUSION FOLLOWING KNEE REPLACEMENT SURGERY.
TRANSFUSION NURSE SPECIALIST - AN EXPANDING ROLE?
EVALUATION OF IRON STATUS IN FREQUENT REGULAR MALE BLOOD DONORS
RED CELL TRANSFUSION PRACTICE IN A LONDON TEACHING HOSPITAL: AN AUDIT
HYPERACTIVE PLATELETS: SHORTENED CLOSURE TIME (PFA-100™) AFTER MYOCARDIAL INFARCTION.
SEVERE ACQUIRED BLEEDING DISORDER CAUSED BY IMMUNE-MEDIATED PLATELET DYSFUNCTION WITHOUT THROMBOCYTOPAENIA.
FEASIBILITY AND OUTCOME OF LAPAROSCOPIC SPLENECTOMY FOR HAEMATOLOGICAL DISORDERS.
THE USE OF PLATELET FUNCTION TESTING TO PREDICT BLEEDING AND ASSESS ASPIRIN SENSITIVITY IN CORONARY ARTERY BYPASS SURGERY.
CHILDHOOD HODGKIN'S DISEASE IN NORTH-WESTERN IRAN.
BONE MINERAL DENSITY AND BODY COMPOSITION IN LONG TERM SURVIVORS OF CHILDHOOD LEUKAEMIAS
HERITABLE THROMBOPHILIC DEFECTS IN LEGG-PERTHES DISEASE
DETECTION AND SIGNIFICANCE OF CHROMOSOMAL ABNORMALITIES IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA IN THE UNITED KINGDOM.
THE t(12;21) TRANSLOCATION AT DIAGNOSIS AND RELAPSE.
OSTEOPOROSIS COMPLICATING ACUTE LYMPHOBLASTIC LEUKAEMIA AND THERAPY, SUCCESSFUL TREATMENT WITH PAMIDRONATE INFUSIONS
ASSESSMENT OF HAEMATOLOGICAL PARAMETERS AND IRON STATUS IN AN INNER CITY PAKISTANI PAEDIATRIC POPULATION
ABNORMAL APOPTOSIS IN FANCONI'S ANAEMIA LYMPHOBLASTOID CELLS.
SERUM FROM FANCONI'S ANAEMIA (FA) PATIENTS HAS A STIMULATORY, RATHER THAN INHIBITORY, EFFECT ON FA AND NORMAL HAEMOPOIETIC PROGENITORS.
FLOW CYTOMETRY IN PNH: SERIAL ANALYSES AND THE PREDICTION OF OUTCOME.
A NEW MUTATION IN HuABC7 IN X-LINKED SIDEROBLASTIC ANAEMIA/ATAXIA (XLSA/A)
TREATMENT OF AUTOIMMUNE CYTOPENIAS WITH THE MONOCLONAL ANTIBODY CAMPATH-1H
LOCUS HETEROGENEITY IN FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
CLINICAL EXPERIENCE WITH G-CSF MOBILISED NORMAL DONOR GRANULOCYTES:
HAEMOCHROMATOSIS - HFE MUTATIONS AND IRON STATUS IN 10,000 BLOOD DONORS FROM SOUTH WALES.
GENOTYPIC DIAGNOSIS OF FACTOR VII DEFICIENCY BY ANALYSIS OF F7 AND F10 GENE POLYMORPHISMS
VWF-CLEAVING PROTEASE ACTIVITY IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP).
MOLECULAR INSIGHTS INTO THE ANTI-INFLAMMATORY PROPERTIES OF ACTIVATED PROTEIN C.
ARE ELEVATED LEVELS OF COAGULATION FACTOR VIII IN THROMBOSIS PATIENTS EXPLAINED BY GAIN OF FUNCTION MUTATIONS IN THE EXONS ENCODING THE FACTOR VIII BINDING DOMAIN OF VON WILLEBRAND FACTOR?
RELEASE OF VON WILLEBRAND FACTOR FROM HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS INDUCED BY RECOMBINANT FACTOR VIIa (rFVIIa).
PATIENT SELF-DETERMINED INRS : ARE THEY UNDER CONTROL?
THE CYSTATHIONINE β-SYNTHASE GENE 844ins68 POLYMORPHISM AND THE RISK FOR VENOUS THROMBOSIS.
SNLG HD3 STUDY: A RANDOMISED TRIAL COMPARING 3 COURSES OF CONTINUOUS HYBRID CHEMOTHERAPY PLUS AUTO TRANSPLANT VERSUS 5 COURSES OF HYBRID TREATMENT IN POOR RISK HODGKIN'S DISEASE AT DIAGNOSIS.
IMMUNOTHERAPY OF LEUKAEMIA USING MEMBRANE-ANCHORED GM-CSF.
PREDICTING RELAPSE IN APL BY QUANTITATING PML-RARA TRANSCRIPTS WITH A HIGHLY SENSITIVE COMPETITIVE RT-PCR.
DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) IN APL BY "REAL-TIME" RT-PCR: ANALYSIS OF CASES ENTERED INTO THE MRC ATRA TRIAL
IN CHRONIC LYMPHOCYTIC LEUKAEMIA SURFACE CD38 POSITIVITY IS AN INDEPENDENT POOR PROGNOSTIC FACTOR. IT DOES NOT CORRELATE WITH V GENE MUTATIONAL STATUS.
CAMPATH-1H THERAPY IN PATIENTS WITH REFRACTORY CLL: OBTAINING DURABLE COMPLETE REMISSION
REVERSING BCL-2 FUNCTION VIA THE MITOCHONDRIAL BENZODAZEPINE RECEPTOR: A NEW SMALL MOLECULE STRATEGY FOR IN VIVO CHEMOSENSITISATION
ALA-10 MUTATIONS IN THE FACTOR IX PROPEPTIDE AND HAEMORRHAGE ON WARFARIN
MOLECULAR ANALYSIS FOR FACTOR XIII DEFICIENCY
INVESTIGATION OF VITAMIN K DEFICIENCY IN A GENERAL INTENSIVE CARE UNIT.
UNEXPECTED PRESENTATION OF TYPE 2N VON WILLEBRANDS DISEASE IN PREGNANCY.
VASCULAR ENDOTHELIAL CELLS ARE A MAJOR SOURCE OF FACTOR VIII EXPRESSION.
RECOMBINANT FACTOR VIIa IN PATIENTS WITH FVIII INHIBITORS AND PROTHROMBIN COMPLEX CONCENTRATE (PCC) RELATED MYOCARDIAL INFARCTION (MI)
TREATMENT WITH CLOTTING FACTOR CONCENTRATES IN PATIENTS WITH VON WILLEBRAND DISEASE (VWD) UNDERGOING SCHEDULED SURGERY
CONGENITAL COMBINED DEFICIENCIES OF VON WILLEBRAND FACTOR AND OTHER CLOTTING FACTORS IN A LARGE POPULATION WITH VON WILLEBRAND DISEASE
EVALUATION OF PATIENTS TREATED WITH PCC BPL (9A) FOLLOWING LIFE THREATENING HAEMORRHAGE
FIBRINOLYTIC ACTIONS OF INTRA-ARTERIAL ANGIOTENSIN II AND BRADYKININ IN VIVO IN MAN
HYPERCHOLESTEROLAEMIA AND LIPID LOWERING THERAPY DO NOT AFFECT THE ACUTE ENDOGENOUS FIBRINOLYTIC CAPACITY IN VIVO
LOCAL AND SYSTEMIC EFFECTS OF INTRA-ARTERIAL DESMOPRESSIN IN HEALTHY VOLUNTEERS AND PATIENTS WITH VON WILLEBRAND DISEASE: ROLE OF INTERLEUKIN-6
CONTINUOUS INFUSION OF PORCINE FVIII IN PATIENTS WITH HAEMOPHILIA A AND INHIBITORS.
IS EAR-PIERCING A SIGNIFICANT HAEMOSTATIC CHALLENGE IN WOMEN WITH MILD BLEEDING DISORDERS?
HETEROGENOUS EXPRESSION OF THE ABO BLOOD GROUP ANTIGENS OF VON WILLEBRAND FACTOR.
VON WILLEBRAND'S DISEASE IN PATIENTS PRESENTING WITH MENORRHAGIA.
PLASMA HOMOCYST(E)INE LEVELS IN THE ACUTE AND CONVALESCENT PHASES OF ATHEROTHROMBOTIC STROKE.
A RETROSPECTIVE FOLLOW-UP STUDY OF ORAL ANTICOAGULANT CONTROL AND HAEMORRHAGIC COMPLICATIONS IN AN ELDERLY POPULATION WITH ATRIAL FIBRILLATION
INTRAVENOUS DRUG ABUSE IS A COMMON PRECIPITATING FACTOR FOR DVT AMONGST FEMALES IN GLASGOW.
NYCOMED RAPID IMMUNOASSAY FOR MEASUREMENT OF D-DIMERS IN PATIENTS WITH SUSPECTED VENOUS THROMBOEMBOLISM.
MONITORING OF CLINICAL EFFECTIVENESS OF D-DIMER SCREENING TESTS FOR SUSPECTED DVT IS ESSENTIAL.
CONTRASTING EFFECTS OF HSP72 EXPRESSION OF APOPTOSIS IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS AND AN ANGIOGENIC CELL LINE ECV 304.
THE EFFICACY OF THE BIRMINGHAM MODEL OF ANTICOAGULATION IN ROUTINE PRACTICE.
A PRIMARY CARE BASED STUDY OF PATIENT SELF-MANAGEMENT OF ORAL ANTICOAGULATION.
USE OF SIMPLIRED D-DIMER AND CLINICAL ASSESSMENT TO EXCLUDE PATIENTS WITHOUT PULMONARY EMBOLISM FROM FURTHER INVESTIGATIONS.
CD77 EXPRESSION, ITS REGULATION AND ROLE IN VEROTOXIN-MEDIATED APOPTOSIS:
NEUROLOGICAL EVENTS IN PATIENTS ON ORAL ANTICOAGULANT THERAPY: A REGIONAL REPORTING SCHEME IN MERSEYSIDE AND NORTH WALES
D-DIMER AS A SCREENING TEST FOR DEEP VENOUS THROMBOSIS (DVT): QUANTITATIVE STUDIES AND CUT-OFF VALUES FOR VENOUS ULTRASONOGRAPHY.
MARKERS OF ENDOTHELIAL CELL DYSFUNCTION IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME
EVALUATION OF PROTEIN C INHIBITOR AS A CANDIDATE GENE IN MYOCARDIAL INFARCTION
LIPOPROTEIN (a), CHOLESTEROL AND TRIGLYCERIDES IN WOMEN WITH VENOUS THROMBOEMBOLISM
THE MECHANISM OF REGULATION BY THE ANTI-INFLAMMATORY CYTOKINE, INTERLEUKIN-4 ON THE ENDOTHELIAL PROTEIN C RECEPTOR.
D DIMER AS A SCREENING TEST FOR DEEP VEIN THROMBOSIS (DVT): ASSESSMENT OF A BED SIDE TEST (SIMPLI RED) IN 497 PATIENTS.
UPPER EXTREMITY VENOUS THROMBOSIS FOLLOWING OVARIAN HYPERSTIMULATION.
UNFRACTIONATED HEPARIN IN THE MANAGEMENT OF SEVERE ACTIVE INFLAMMATORY BOWEL DISEASE.
COMPARISON OF AN AUTOMATED ONE-STAGE ANTI Xa CLOTTING ASSAY WITH A CHROMOGENIC ASSAY TO MEASURE THE CONCENTRATION OF LOW MOLECULAR WEIGHT HEPARIN IN PREGNANT WOMEN.
THE TREATMENT AND INVESTIGATION OF YOUNGER MEN PRESENTING IN THE COMMUNITY WITH IRON DEFICIENCY ANAEMIA
THE TREATMENT AND RESOLUTION OF IRON DEFICIENCY ANAEMIA IN A LARGE COMMUNITY-BASED STUDY
COST UTILITY ANALYSIS OF THE ZINC PROTOPORPHYRIN ASSAY AS AN INITIAL SCREEN FOR IRON DEFICIENT ERYTHROPOIESIS.
DETECTION OF FACTOR XIII DEFICIENCY: WHICH TEST?
CLOSURE OF HOSPITAL-BASED ANTICOAGULANT CLINICS - A SHIFT FROM SECONDARY TO PRIMARY CARE.
ASSESSMENT OF A FLOW CYTOMETRIC ASSAY FOR THE DIAGNOSIS OF HEREDITARY SPHEROCYTOSIS IN A PAEDIATRIC HAEMATOLOGY LABORATORY.
THROMBOPHILIA SCREENING IN A DISTRICT GENERAL HOSPITAL - REQUESTING PATTERNS, ABNORMALITIES & PERCEIVED CLINICAL VALUE
USE OF 'NEW' NYCOCARD D-DIMER ASSAY FOR NEGATIVE PREDICTABILITY OF DEEP VEIN THROMBOSIS.
PHLEBOTOMY TREATMENT OF HEREDITARY HAEMOCHROMATOSIS: WHERE IS THE EVIDENCE?
A new training and accreditation framework for phlebotomists
The ADVIA 120 PROVIDES NEW PREDICTIVE PARAMETERS FOR ASSESSMENT OF ANAEMIA.
THE USE OF LEU3b FOR THE ACCURATE DETERMINATION OF CD4 SUBSETS BY MEASUREMENT OF INTRACELLULAR CYTOKINES
DELAYED INR MEASUREMENT IN PATIENTS ON WARFARIN - 24 HOURS AT ROOM TEMPERATURE (BUT NOT 4°C) ASSOCIATED WITH NEGLIGIBLE CHANGE.
CYTOMEGALOVIRUS INFECTION IN LOW RISK ALLOGENEIC BONE MARROW TRANSPLANTS DETECTED BY PCR DESPITE THE USE OF CMV NEGATIVE, LEUCODEPLETED PRODUCTS.
Adenovirus infections in haematopoetic stem cell transplant (SCT) recipients: a prospective surveillance study.
INTRACELLULAR CD34 ANALYSIS OF AC133+ CELL SUBSETS.
ESTABLISHMENT OF A COMMUNITY-BASED AUTOLOGOUS BLOOD STEM CELL TRANSPLANT SERVICE IN THE UK.
ALLOGENEIC TRANSPLANTATION FOR LYMPHOPROLIFERATIVE DISORDERS USING BEAM/CAMPATH CONDITIONING ANALYSIS OF CHIMERISM AND GVHD.
ENDOGENOUS G-CSF PROMOTES NEUTROPHIL RECOVERY POST AUTOLOGOUS TRANSPLANTATION.
A HIGHLY IMMUNOSUPPRESSIVE CONDITIONING REGIMEN FOR HIGH RISK PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
HIGH RATE OF CMV REACTIVATION (BUT NOT DISEASE) IN RECIPIENTS OF ALLOGENEIC TRANSPLANTS CONDITIONED WITH CAMPATH 1H
ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES (MDS): A SINGLE CENTRE EXPERIENCE.
Transplantation of non-cryopreserved stem cells in patients with multiple myeloma.
IMPROVING QUALITY OF BLOOD AND MARROW TRANSPLANTATION COMMISSIONING 1995 - 2000
INTRAVENOUS ITRACONAZOLE CAN REPLACE ORAL SOLUTION IN ASPERGILLOSIS PROPHYLAXIS: PHARMACOKINETIC DATA FROM PATIENTS TREATED FOR HAEMATOLOGICAL MALIGNANCIES.
SUSTAINED ENGRAFTMENT OF PLATELETS FOLLOWING PBSCT OR BMT ARE INFLUENCED BY NUMBERS OF CD34+ CELLS AND CFU-GM INFUSED.
EVI1 EXPRESSION IN ACUTE MYELOID LEUKAEMIA.
GENE EXPRESSION USING ADENOVIRAL VECTORS IN PRIMARY ACUTE LEUKAEMIA CELLS.
ANALYSIS OF THE INHIBITORY EFFECT OF LEUKAEMIC CELLS ON T CELL ACTIVATION.
INDUCTION OF DIFFERENTIATION IN LEUKAEMIC CELL LINES USING NOVEL RETINOIDS.
ACUTE LYMPHOBLASTIC LEUKAMIA IN ADULTS; A POPULATION BASED STUDY OF INCIDENCE AND OUTCOME OVER A 16 YEAR PERIOD.
HIGH BAX EXPRESSION IS A GOOD PROGNOSTIC INDICATOR IN ACUTE MYELOID LEUKAEMIA.
INTERPHASE FISH AS A PROGNOSTIC INDICATOR IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA.
SEQUENTIAL FISH IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA.
GENE EXPRESSION OF MULTIDRUG RESISTANT PROTEIN (MRP) HOMOLOGUES IN B-CLL AND AML CELLS.
IN VITRO CULTURE SYSTEM TO STUDY THE ORIGIN OF MULTIPLE VHDJH RECOMBINATIONS IN PAEDIATRIC ALL
CENTRAL NERVOUS SYSTEM RELAPSE AFTER STEM CELL TRANSPLANTATION (SCT)FOR ACUTE LEUKEMIA BEYOND FIRST REMISSION
ACTIVATION OF CASPASE 8 IN THE ABSENCE OF FAS LIGATION IN THE KILLING OF B-CLL CELLS BY CYTOTOXIC DRUGS AND RADIATION.
PREDICTING CLINICAL OUTCOME IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA BY MONITORING MINIMAL RESIDUAL DISEASE.
INCREASE IN CYTOPLASMIC CYTOCHROME C IS NOT A RATELIMITING STEP IN THE INDUCTION OF APOPTOSIS OF B-CLL CELLS.
THE AKT PROTEIN KINASE MEDIATES PLASMA-INDUCED SURVIVAL OF B-CLL CELLS.
INTERFERON-α AND ZIDOVUDINE THERAPY IN ADULT T-CELL LEUKAEMIA LYMPHOMA (ATLL). RESPONSE AND OUTCOME IN 15 PATIENTS FROM THE UK.
INVESTIGATION OF CD5+CD23− B CELL LEUKAEMIA FOR THE PRESENCE OF t(11;14)(q13;q32) USING 2-COLOUR FISH
PROGNOSTIC MARKERS IN PATIENTS WITH SPLENIC LYMPHOMA WITH VILLOUS LYMPHOCYTES
KINETIC MODELLING OF CHEMOTHERAPY INDUCED APOPTOSIS IN LYMPHOMA: MEDIAN RATE OF MITOCHONDRIAL PERMEABILITY TRANSITION AS AN INDEX OF CHEMOSENSITIVITY
CELLULAR EX VIVO DRUG SENSITIVITY ELUCIDATED BY DiSC ASSAY SHOWS NO DIFFERENCE FOR OLDER CLL PATIENTS: RESPONSE AND SURVIVAL DISADVANTAGE MAY BE DUE TO EMPIRICAL UNDERTREATMENT FOR THIS GROUP
CHRONIC LYMPHOCYTIC LEUKAEMIA B-CELL LYSATE-PULSED, AUTOLOGOUS DENDRITIC CELLS INDUCE T-CELL PROLIFERATION AND HLA CLASS II-RESTRICTED, ANTILEUKAEMIC CYTOTOXICITY.
DYSREGULATION OF T LYMPHOCYTE ACTIVATION MARKERS IN B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA.
IL2 mRNA IS SYNTHESISED BY CHRONIC LYMPHOCYTIC LEUKAEMIA B-CELLS.
MUTATIONS OF THE HFE GENE AND THE RISK OF HEPATOCELLULAR CARCINOMA.
CONFOCAL LASER SCANNING COMPARISON OF AC133 AND CD34 SURFACE ANTIGENS.
SURFACE PLASMON RESONANCE DETECTS ANTIBODIES TO FXII WHEN FXII IS BOUND TO PHOSPHATIDYLSERINE.
HAEMATOLOGY TELECLINICS:A PILOT STUDY
TARGETED RADIOTHERAPY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES: PRE-CLINICAL EVALUATION OF A RADIOLABELLED MONOCLONAL ANTI-CD45 ANTIBODY FOR TRANSPLANT CONDITIONING AND INITIAL CLINICAL DOSIMETRY RESULTS.
Implementation and performance improvement by monitoring of point of care testing (POCT) for INR'S in Primary Care.
REPORT FOR BSH
THE ORAL CONTRACEPTIVE RELATED THROMBOTIC RISK IS SIMILAR IN AFFECTED AND UNAFFECTED RELATIVES OF WOMEN WITH THROMBOPHILIA
TYPE 1 INOSITOL POLYPHOSPATE-4-PHOSPHATASE IS A POSSIBLE DOWNSTREAM TARGET OF GATA-1 AND REGULATES GROWTH OF MULTIPLE CELL TYPES INCLUDING PRIMARY MEGAKARYOCYTES.
THE ROLE OF MURINE ANTICHYMOTRYPSIN-LIKE SERPINS IN CELL GROWTH AND DIFFERENTIATION.
ACTIVATION OF CYCLIN D2-CDK6/4 IN HEMATOPOIETIC PROGENITOR CELLS COORDINATES ENTRY INTO THE CELL CYCLE.
TRANSFORMING GROWTH FACTOR-β (TGFβ) INHIBITS INTERLEUKIN-2 (IL-2) AUTOCRINE PATHWAY ENTRY BY SUPPRESSING IL-2 RECEPTOR α GENE INDUCTION IN PRIMARY T- CELLS.